Objectives: A post-marketing surveillance (PMS) study was conducted to evaluate the efficacy and tolerability of treatment with moxifloxacin 400mg once daily in patients with acute exacerbations of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results